# Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail

> **NCT02343627** · PHASE2 · COMPLETED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 47 (actual)

## Conditions studied

- Onychomycosis

## Interventions

- **DRUG:** NVXT Solution
- **DRUG:** Vehicle of test product

## Key facts

- **NCT ID:** NCT02343627
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2018-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02343627

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02343627, "Safety and Efficacy of NVXT Solution in Mild-to-Moderate Fungal Infection of the Toe Nail". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT02343627. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*